Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States
Coronavirus 2019 (COVID-19) pneumonia was first noted in Wuhan, China. Since the start of the pandemic, there have been millions of cases diagnosed. The average time from onset of symptoms to testing negative SARS-CoV-2 via reverse transcription polymerase chain reaction is roughly 25 days. In patie...
Main Authors: | , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2021-08-01
|
Series: | SAGE Open Medical Case Reports |
Online Access: | https://doi.org/10.1177/2050313X211040028 |
id |
doaj-5947a1f7417547d187f7b9ce199ae247 |
---|---|
record_format |
Article |
spelling |
doaj-5947a1f7417547d187f7b9ce199ae2472021-08-13T22:03:29ZengSAGE PublishingSAGE Open Medical Case Reports2050-313X2021-08-01910.1177/2050313X211040028Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United StatesBilal Chaudhry0Lidiya Didenko1Maaria Chaudhry2Andrew Malek3Kirill Alekseyev4Christiana Care Health System., Newark, DE, USAPost-Acute Medical Rehabilitation Hospital of Dover, Dover, DE, USAChristiana Care Health System., Newark, DE, USAPost-Acute Medical Rehabilitation Hospital of Dover, Dover, DE, USAPost-Acute Medical Rehabilitation Hospital of Dover, Dover, DE, USACoronavirus 2019 (COVID-19) pneumonia was first noted in Wuhan, China. Since the start of the pandemic, there have been millions of cases diagnosed. The average time from onset of symptoms to testing negative SARS-CoV-2 via reverse transcription polymerase chain reaction is roughly 25 days. In patients who continually test positive for COVID-19, it is essential to determine precisely which risk factors contribute to the increase in viral shedding duration. We present a case about a 62-year-old man who has persistently tested positive for COVID-19 for more than 230 days. We followed his treatment course, in which he had been hospitalized multiple times since the onset of symptoms back in April 2020. We have determined that patients with immunosuppression, especially those taking corticosteroids, are at increased risk of prolonged viral shedding. It is essential to continually monitor these immunocompromised patients as they required a greater time period in order to have an appropriate immune response in which antibodies are created.https://doi.org/10.1177/2050313X211040028 |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Bilal Chaudhry Lidiya Didenko Maaria Chaudhry Andrew Malek Kirill Alekseyev |
spellingShingle |
Bilal Chaudhry Lidiya Didenko Maaria Chaudhry Andrew Malek Kirill Alekseyev Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States SAGE Open Medical Case Reports |
author_facet |
Bilal Chaudhry Lidiya Didenko Maaria Chaudhry Andrew Malek Kirill Alekseyev |
author_sort |
Bilal Chaudhry |
title |
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States |
title_short |
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States |
title_full |
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States |
title_fullStr |
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States |
title_full_unstemmed |
Longest reported case of symptomatic COVID-19 reporting positive for over 230 days in an immunocompromised patient in the United States |
title_sort |
longest reported case of symptomatic covid-19 reporting positive for over 230 days in an immunocompromised patient in the united states |
publisher |
SAGE Publishing |
series |
SAGE Open Medical Case Reports |
issn |
2050-313X |
publishDate |
2021-08-01 |
description |
Coronavirus 2019 (COVID-19) pneumonia was first noted in Wuhan, China. Since the start of the pandemic, there have been millions of cases diagnosed. The average time from onset of symptoms to testing negative SARS-CoV-2 via reverse transcription polymerase chain reaction is roughly 25 days. In patients who continually test positive for COVID-19, it is essential to determine precisely which risk factors contribute to the increase in viral shedding duration. We present a case about a 62-year-old man who has persistently tested positive for COVID-19 for more than 230 days. We followed his treatment course, in which he had been hospitalized multiple times since the onset of symptoms back in April 2020. We have determined that patients with immunosuppression, especially those taking corticosteroids, are at increased risk of prolonged viral shedding. It is essential to continually monitor these immunocompromised patients as they required a greater time period in order to have an appropriate immune response in which antibodies are created. |
url |
https://doi.org/10.1177/2050313X211040028 |
work_keys_str_mv |
AT bilalchaudhry longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates AT lidiyadidenko longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates AT maariachaudhry longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates AT andrewmalek longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates AT kirillalekseyev longestreportedcaseofsymptomaticcovid19reportingpositiveforover230daysinanimmunocompromisedpatientintheunitedstates |
_version_ |
1721208093781524480 |